Fundz

BrickBio, Inc. raised an undisclosed amount of funding from Samsung affiliates to develop advanced molecules and therapies using its proprietary protein engineering technology for antibody-drug conjugates (ADCs), AAV gene therapy, and other modalities.

PRIVATEMar 18, 2024

Round Type

Funding Round

WalthamBiotechnologyTherapeuticsBiopharma

Investors

Samsung VenturesSamsung Life Science Fund

Description

Samsung Life Science Fund, created jointly between Samsung Biologics, Samsung Bioepis, and Samsung C&T, and managed by Samsung Ventures, announced its investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code.

Quick answer

BrickBio raised an undisclosed amount in a Funding Round round, dated March 18, 2024. Investors: Samsung Ventures and Samsung Life Science Fund. BrickBio is based in Waltham, Massachusetts, United States.

How much did BrickBio raise?
BrickBio raised an undisclosed amount in a Funding Round round on March 18, 2024.
Who invested in BrickBio?
Samsung Ventures and Samsung Life Science Fund are named as investors in this round.
What does BrickBio do?
BrickBio, Inc. is a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code.
Where is BrickBio based and how big is it?
BrickBio is based in Waltham, Massachusetts, United States.
Who are the decision-makers at BrickBio?
Fundz holds 1 contact at BrickBio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as BrickBio that raised within 45 days of this round, from Fundz verified event records.

  • Bio Green Med Solution, Inc. raised $8M on May 2, 2024.
  • Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
  • TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
  • BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
  • Seaport Therapeutics raised $100M (Series A) on April 9, 2024.
  • TORL BioTherapeutics raised $158M on April 4, 2024.

Who to call at BrickBio, and when

A new round usually means BrickBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BrickBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BrickBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BrickBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BrickBio

Location

Waltham, Massachusetts, United States

About

BrickBio, Inc. is a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code. The company empowers next-generation unnatural amino acid coupled protein conjugation with its site-specific and site-selective platform, enabling the development of unique biologics and protein therapeutics with enhanced characteristics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BrickBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for BrickBio's next move

See what Strategic adds

BrickBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.